收稿日期: 2020-11-04
网络出版日期: 2022-06-28
基金资助
国家自然科学基金(81670791)
李少博, 杨迪, 韩峻峰 . 身体成分变化与非酒精性脂肪性肝病的相关研究进展[J]. 诊断学理论与实践, 2021 , 20(01) : 104 -108 . DOI: 10.16150/j.1671-2870.2021.01.017
| [1] | Fan JG, Kim SU, Wong VW. New trends on obesity and NAFLD in Asia[J]. J Hepatol, 2017, 67(4):862-873. |
| [2] | Trouwborst I, Verreijen A, Memelink R, et al. Exercise and nutrition strategies to counteract sarcopenic obesity[J]. Nutrients, 2018, 10(5):605. |
| [3] | Dulloo AG, Jacquet J, Solinas G, et al. Body composition phenotypes in pathways to obesity and the metabolic syndrome[J]. Int J Obes (Lond), 2010, 34(Suppl 2):S4-S17. |
| [4] | Hong SH, Choi KM. Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences[J]. Int J Mol Sci, 2020, 21(2):494. |
| [5] | Al-Sofiani ME, Ganji SS, Kalyani RR. Body composition changes in diabetes and aging[J]. J Diabetes Complications, 2019, 33(6):451-459. |
| [6] | Albano D, Messina C, Vitale J, et al. Imaging of sarcopenia: old evidence and new insights[J]. Eur Radiol, 2020, 30(4):2199-2208. |
| [7] | Koster A, Visser M, Simonsick EM, et al. Association between fitness and changes in body composition and muscle strength[J]. J Am Geriatr Soc, 2010, 58(2):219-226. |
| [8] | Siervogel RM, Wisemandle W, Maynard LM, et al. Serial changes in body composition throughout adulthood and their relationships to changes in lipid and lipoprotein levels. The Fels Longitudinal Study[J]. Arterioscler Thromb Vasc Biol, 1998, 18(11):1759-1764. |
| [9] | Hughes VA, Frontera WR, Roubenoff R, et al. Longitudinal changes in body composition in older men and wo-men: role of body weight change and physical activity[J]. Am J Clin Nutr, 2002, 76(2):473-481. |
| [10] | Wang Z, Xu M, Peng J, et al. Prevalence and associated metabolic factors of fatty liver disease in the elderly[J]. Exp Gerontol, 2013, 48(8):705-709. |
| [11] | Wijarnpreecha K, Panjawatanan P, Aby E, et al. Nonalcoholic fatty liver disease in the over-60s: impact of sarcopenia and obesity[J]. Maturitas, 2019, 124:48-54. |
| [12] | Cha JY, Kim DH, Chun KH. The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis[J]. Lab Anim Res, 2018, 34(4):133-139. |
| [13] | Pownall HJ, Schwartz AV, Bray GA, et al. Changes in regional body composition over 8 years in a randomized lifestyle trial: The look AHEAD study[J]. Obesity (Silver Spring), 2016, 24(9):1899-1905. |
| [14] | Hita-Contreras F, Bueno-Notivol J, Martínez-Amat A, et al. Effect of exercise alone or combined with dietary supplements on anthropometric and physical performance measures in community-dwelling elderly people with sarcopenic obesity: a meta-analysis of randomized controlled trials[J]. Maturitas, 2018, 116:24-35. |
| [15] | Villareal DT, Chode S, Parimi N, et al. Weight loss, exer-cise, or both and physical function in obese older adults[J]. N Engl J Med, 2011, 364(13):1218-1229. |
| [16] | Hannah WN Jr, Harrison SA. Effect of weight loss, diet, exercise, and bariatric surgery on nonalcoholic fatty liver disease[J]. Clin Liver Dis, 2016, 20(2):339-350. |
| [17] | Dieli-Conwright CM, Courneya KS, Demark-Wahnefried W, et al. Effects of aerobic and resistance exercise on metabolic syndrome, sarcopenic obesity, and circulating biomarkers in overweight or obese survivors of breast cancer: a randomized controlled trial[J]. J Clin Oncol, 2018, 36(9):875-883. |
| [18] | Buchwald H, Buchwald JN. Metabolic (bariatric and nonbariatric) surgery for type 2 diabetes: a personal perspective review[J]. Diabetes Care, 2019, 42(2):331-340. |
| [19] | Tamboli RA, Hossain HA, Marks PA, et al. Body composition and energy metabolism following Roux-en-Y gastric bypass surgery[J]. Obesity (Silver Spring), 2010, 18(9):1718-1724. |
| [20] | Pontiroli AE, Folli F, Paganelli M, et al. Laparoscopic gastric banding prevents type 2 diabetes and arterial hypertension and induces their remission in morbid obesity: a 4-year case-controlled study[J]. Diabetes Care, 2005, 28(11):2703-2709. |
| [21] | Metcalf B, Rabkin RA, Rabkin JM, et al. Weight loss composition: the effects of exercise following obesity surgery as measured by bioelectrical impedance analysis[J]. Obes Surg, 2005, 15(2):183-186. |
| [22] | Alba DL, Wu L, Cawthon PM, et al. Changes in lean mass, absolute and relative muscle strength, and physical performance after gastric bypass surgery[J]. J Clin Endocrinol Metab, 2019, 104(3):711-720. |
| [23] | Lassailly G, Caiazzo R, Buob D, et al. Bariatric surgery reduces features of nonalcoholic steatohepatitis in morbidly obese patients[J]. Gastroenterology, 2015, 149(2):379-388,e15-e16. |
| [24] | Lee Y, Doumouras AG, Yu J, et al. Complete resolution of nonalcoholic fatty liver disease after bariatric surgery: a systematic review and meta-analysis[J]. Clin Gastroenterol Hepatol, 2019, 17(6):1040-1060. |
| [25] | Immonen H, Hannukainen JC, Kudomi N, et al. Increased liver fatty acid uptake is partly reversed and liver fat content normalized after bariatric surgery[J]. Diabetes Care, 2018, 41(2):368-371. |
| [26] | Froylich D, Corcelles R, Daigle C, et al. Effect of Roux-en-Y gastric bypass and sleeve gastrectomy on nonalcoholic fatty liver disease: a comparative study[J]. Surg Obes Relat Dis, 2016, 12(1):127-131. |
| [27] | Poggiogalle E, Donini LM, Lenzi A, et al. Non-alcoholic fatty liver disease connections with fat-free tissues: a focus on bone and skeletal muscle[J]. World J Gastroenterol, 2017, 23(10):1747-1757. |
| [28] | Kim JA, Choi KM. Sarcopenia and fatty liver disease[J]. Hepatol Int, 2019, 13(6):674-687. |
| [29] | Kalinkovich A, Livshits G. Sarcopenic obesity or obese sarcopenia: a cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mecha-nism of the pathogenesis[J]. Ageing Res Rev, 2017, 35:200-221. |
| [30] | Pacifico L, Perla FM, Chiesa C. Sarcopenia and nonalcoholic fatty liver disease: a causal relationship[J]. Hepatobiliary Surg Nutr, 2019, 8(2):144-147. |
| [31] | Cleasby ME, Jamieson PM, Atherton PJ. Insulin resistance and sarcopenia: mechanistic links between common co-morbidities[J]. J Endocrinol, 2016, 229(2):R67-R81. |
| [32] | Riddle RC, Clemens TL. Insulin, osteoblasts, and energy metabolism: why bone counts calories[J]. J Clin Invest, 2014 Apr; 124(4):1465-1467. |
| [33] | Karampela I, Christodoulatos GS, Dalamaga M. The role of adipose tissue and adipokines in sepsis: inflammatory and metabolic considerations, and the obesity paradox[J]. Curr Obes Rep, 2019, 8(4):434-457. |
| [34] | Scott IC, Tomlinson W, Walding A, et al. Large-scale isolation of human skeletal muscle satellite cells from post-mortem tissue and development of quantitative assays to evaluate modulators of myogenesis[J]. J Cachexia Sarcopenia Muscle, 2013, 4(2):157-169. |
| [35] | Budick-Harmelin N, Dudas J, Demuth J, et al. Triglyce-rides potentiate the inflammatory response in rat Kupffer cells[J]. Antioxid Redox Signal, 2008, 10(12):2009-2022. |
| [36] | Jiang W, Wu N, Wang X, et al. Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease[J]. Sci Rep, 2015, 5:8096. |
| [37] | Poggiogalle E, Lubrano C, Gnessi L, et al. Fatty liver index associates with relative sarcopenia and GH/IGF-1 status in obese subjects[J]. PLoS One, 2016, 11(1):e0145811. |
| [38] | Cabrera D, Ruiz A, Cabello-Verrugio C, et al. Diet-induced nonalcoholic fatty liver disease is associated with sarcopenia and decreased serum insulin-like growth factor-1[J]. Dig Dis Sci, 2016, 61(11):3190-3198. |
| [39] | Cabrera D, Cabello-Verrugio C, Solís N, et al. Somatotropic axis dysfunction in non-alcoholic fatty liver di-sease: beneficial hepatic and systemic effects of hormone supplementation[J]. Int J Mol Sci, 2018, 19(5):1339. |
/
| 〈 |
|
〉 |
